1. Home
  2. |Insights
  3. |PODCAST: President Trump’s Early Trade Policy Moves – What it Means for Business — C&M’s First 100 Days Series

PODCAST: President Trump’s Early Trade Policy Moves – What it Means for Business — C&M’s First 100 Days Series

Client Alert | 1 min read | 02.03.17

As part of Crowell & Moring’s “First 100 Days” series, Paul Davies and Andrew Blasi of C&M International, Crowell & Moring’s international policy and regulatory affairs consulting affiliate, discuss the trade policy moves made so far by the Trump Administration, and what it means for businesses who are involved in trade issues. Paul is a director at C&M International and a former Australian trade negotiator. Andrew is an associate director at C&M International and a former staff member of the US-ASEAN Business Council and the U.S. House of Representatives.

Covered in this 16 minute podcast:

  • President Trump’s early trade policy emphasis on limiting imports and eliminating the trade deficit.
  • Implications of the U.S. withdrawal from TPP and the main takeaways for businesses.
  • The president’s upcoming meeting with Prime Minister Abe of Japan and where things stand.
  • Thoughts on NAFTA and what businesses might expect.

Click below to listen or access from one of these links:
PodBean | SoundCloud | iTunes

Insights

Client Alert | 3 min read | 01.21.26

Atlantic Biologicals Opioid DPA: DOJ Continues Ramp Up of Criminal Corporate Healthcare Enforcement

On January 13, 2026, Miami-based pharmaceutical wholesaler Atlantic Biologicals Corporation entered into a two-year DPA, admitting to conspiracy to distribute and dispense controlled substances, including more than 14 million opioid doses to “pill mill” pharmacies in Texas at a markup. The DOJ and DEA underscored the company’s deliberate evasion of compliance checks and disregard for red flags signaling diversion....

View All Insights